174 related articles for article (PubMed ID: 19737951)
21. Prognostic significance and predictive performance of volume-based parameters of F-18 FDG PET/CT in squamous cell head and neck cancers.
Sager S; Asa S; Yilmaz M; Uslu L; Vatankulu B; Halaç M; Sönmezoglu K; Kanmaz B
J Cancer Res Ther; 2014; 10(4):922-6. PubMed ID: 25579529
[TBL] [Abstract][Full Text] [Related]
22. Metabolic tumour volume and total lesion glycolysis, measured using preoperative 18F-FDG PET/CT, predict the recurrence of endometrial cancer.
Shim SH; Kim DY; Lee DY; Lee SW; Park JY; Lee JJ; Kim JH; Kim YM; Kim YT; Nam JH
BJOG; 2014 Aug; 121(9):1097-106; discussion 1106. PubMed ID: 24397772
[TBL] [Abstract][Full Text] [Related]
23. Can adaptive threshold-based metabolic tumor volume (MTV) and lean body mass corrected standard uptake value (SUL) predict prognosis in head and neck cancer patients treated with definitive radiotherapy/chemoradiotherapy?
Akagunduz OO; Savas R; Yalman D; Kocacelebi K; Esassolak M
Nucl Med Biol; 2015 Nov; 42(11):899-904. PubMed ID: 26275933
[TBL] [Abstract][Full Text] [Related]
24. Prognostic value of metabolic tumor volume measured by FDG-PET/CT in patients with cervical cancer.
Chung HH; Kim JW; Han KH; Eo JS; Kang KW; Park NH; Song YS; Chung JK; Kang SB
Gynecol Oncol; 2011 Feb; 120(2):270-4. PubMed ID: 21109300
[TBL] [Abstract][Full Text] [Related]
25. Pretreatment (18)F-FDG PET/CT in whole-body total lesion glycolysis to predict survival in patients with pharyngeal cancer treated with definitive radiotherapy.
Chen SW; Hsieh TC; Yen KY; Liang JA; Kao CH
Clin Nucl Med; 2014 May; 39(5):e296-300. PubMed ID: 24217547
[TBL] [Abstract][Full Text] [Related]
26. The role of 18F-FDG PET/CT metabolic tumour volume in predicting survival in patients with metastatic nasopharyngeal carcinoma.
Chan SC; Hsu CL; Yen TC; Ng SH; Liao CT; Wang HM
Oral Oncol; 2013 Jan; 49(1):71-8. PubMed ID: 22959277
[TBL] [Abstract][Full Text] [Related]
27. Initial metabolic tumor volume measured by 18F-FDG PET/CT can predict the outcome of osteosarcoma of the extremities.
Byun BH; Kong CB; Park J; Seo Y; Lim I; Choi CW; Cho WH; Jeon DG; Koh JS; Lee SY; Lim SM
J Nucl Med; 2013 Oct; 54(10):1725-32. PubMed ID: 23949909
[TBL] [Abstract][Full Text] [Related]
28. Intratumor Textural Heterogeneity on Pretreatment (18)F-FDG PET Images Predicts Response and Survival After Chemoradiotherapy for Hypopharyngeal Cancer.
Oh JS; Kang BC; Roh JL; Kim JS; Cho KJ; Lee SW; Kim SB; Choi SH; Nam SY; Kim SY
Ann Surg Oncol; 2015 Aug; 22(8):2746-54. PubMed ID: 25487968
[TBL] [Abstract][Full Text] [Related]
29. Metabolic Tumor Volume Change Predicts Long-term Survival and Histological Response to Preoperative Chemotherapy in Locally Advanced Esophageal Cancer.
Makino T; Yamasaki M; Tanaka K; Masuike Y; Tatsumi M; Motoori M; Kimura Y; Hatazawa J; Mori M; Doki Y
Ann Surg; 2019 Dec; 270(6):1090-1095. PubMed ID: 29727327
[TBL] [Abstract][Full Text] [Related]
30.
Vallius T; Hynninen J; Kemppainen J; Alves V; Auranen K; Matomäki J; Oksa S; Virtanen J; Grénman S; Auranen A; Seppänen M
Eur J Nucl Med Mol Imaging; 2018 Jul; 45(7):1224-1232. PubMed ID: 29476227
[TBL] [Abstract][Full Text] [Related]
31. Prognostic value of 18F-FDG PET-CT metabolic index for nasopharyngeal carcinoma.
Xie P; Yue JB; Zhao HX; Sun XD; Kong L; Fu Z; Yu JM
J Cancer Res Clin Oncol; 2010 Jun; 136(6):883-9. PubMed ID: 19936788
[TBL] [Abstract][Full Text] [Related]
32. ¹⁸F-Fluorodeoxyglucose Positron Emission Tomography for Evaluating the Response to Neoadjuvant Chemotherapy in Advanced Esophageal Cancer.
Tani Y; Nakajima M; Kikuchi M; Ihara K; Muroi H; Takahashi M; Domeki Y; Okamoto K; Yamaguchi S; Sasaki K; Tsuchioka T; Sakamoto S; Kato H
Anticancer Res; 2016 Jan; 36(1):367-73. PubMed ID: 26722067
[TBL] [Abstract][Full Text] [Related]
33. Predictive and prognostic value of metabolic tumor volume (MTV) in patients with laryngeal carcinoma treated by radiotherapy (RT) / concurrent chemoradiotherapy (CCRT).
Yabuki K; Shiono O; Komatsu M; Sano D; Nishimura G; Takahashi M; Taguchi T; Inoue T; Oridate N
PLoS One; 2015; 10(2):e0117924. PubMed ID: 25692986
[TBL] [Abstract][Full Text] [Related]
34. Immunohistochemical studies and fluorodeoxyglucose uptake on positron emission tomography in pharyngeal cancer for predicting radiotherapy-based treatment outcomes.
Lin YC; Chen RY; Chen SW; Hsieh TC; Yen KY; Liang JA; Yang SN; Wang YC; Chen YH; Chow NH; Kao CH
Clin Otolaryngol; 2017 Jun; 42(3):608-619. PubMed ID: 27762071
[TBL] [Abstract][Full Text] [Related]
35. Pretherapeutic FDG-PET total metabolic tumor volume predicts response to induction therapy in pediatric Hodgkin's lymphoma.
Rogasch JMM; Hundsdoerfer P; Hofheinz F; Wedel F; Schatka I; Amthauer H; Furth C
BMC Cancer; 2018 May; 18(1):521. PubMed ID: 29724189
[TBL] [Abstract][Full Text] [Related]
36. Pretreatment metabolic tumor volumes to predict the short-term outcome of unresectable locally advanced squamous cell carcinoma of the esophagus treated with definitive chemoradiotherapy.
Chen SW; Hsieh TC; Ding HJ; Yen KY; Lin CY; Liang JA; Kao CH
Nucl Med Commun; 2014 Mar; 35(3):291-7. PubMed ID: 24276528
[TBL] [Abstract][Full Text] [Related]
37. [18F]Fluorodeoxyglucose uptake by positron emission tomography predicts outcomes for oropharyngeal and hypopharyngeal cancer treated with definitive radiotherapy.
Ishihara T; Kitajima K; Suenaga Y; Ejima Y; Komatsu H; Otsuki N; Nibu KI; Kiyota N; Takahashi S; Sasaki R
Nagoya J Med Sci; 2017 Feb; 79(1):27-36. PubMed ID: 28303058
[TBL] [Abstract][Full Text] [Related]
38. Validation that metabolic tumor volume predicts outcome in head-and-neck cancer.
Tang C; Murphy JD; Khong B; La TH; Kong C; Fischbein NJ; Colevas AD; Iagaru AH; Graves EE; Loo BW; Le QT
Int J Radiat Oncol Biol Phys; 2012 Aug; 83(5):1514-20. PubMed ID: 22270174
[TBL] [Abstract][Full Text] [Related]
39.
Jackson JE; Anderson NJ; Rolfo M; Wada M; Schneider M; Poulsen M; Fahandej M; Huynh A; Lee ST; Joon DL; Khoo V
Dysphagia; 2019 Jun; 34(3):341-349. PubMed ID: 30267142
[TBL] [Abstract][Full Text] [Related]
40. 18F-FDG-PET/CT in a patient with suspected recurrence of germ cell tumor.
Penna D; Arena V; Pelosi E
J Cancer Res Ther; 2013; 9(3):520-2. PubMed ID: 24125998
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]